Johnson & Johnson Files 8-K with Financial Updates

Ticker: JNJ · Form: 8-K · Filed: 2024-10-15T00:00:00.000Z

Sentiment: neutral

Topics: financial-reporting, debt, sec-filing

Related Tickers: JNJ

TL;DR

JNJ filed an 8-K on Oct 15, 2024, showing debt maturities and financial details.

AI Summary

On October 15, 2024, Johnson & Johnson filed an 8-K report detailing financial information. The filing includes details on various notes due in different years, such as A5.50 Notes Due 2024 and A1.150 Notes Due November 2028, indicating ongoing financial operations and debt management.

Why It Matters

This filing provides investors with current information on Johnson & Johnson's financial condition, including details on its outstanding debt obligations.

Risk Assessment

Risk Level: low — This is a routine financial filing with no immediate negative or positive news, making the risk level low.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Johnson & Johnson?

The primary purpose is to report on the Results of Operations and Financial Condition, as well as to file Financial Statements and Exhibits.

What specific debt instruments are mentioned in the filing?

The filing mentions A5.50 Notes Due 2024, A1.150 Notes Due November 2028, A3.20 Notes Due November 2032, A1.650 Notes Due 2035, A3.350 Notes Due November 2036, and A3.550 Notes Due November 2044.

On what date was this 8-K report filed?

The report was filed on October 15, 2024.

What is Johnson & Johnson's state of incorporation and fiscal year end?

Johnson & Johnson is incorporated in New Jersey and its fiscal year ends on December 29.

What is the SIC code for Johnson & Johnson?

The Standard Industrial Classification (SIC) code for Johnson & Johnson is 2834, which corresponds to Pharmaceutical Preparations.

From the Filing

0000200406-24-000088.txt : 20241015 0000200406-24-000088.hdr.sgml : 20241015 20241015073720 ACCESSION NUMBER: 0000200406-24-000088 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20241015 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20241015 DATE AS OF CHANGE: 20241015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 241369274 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20241015.htm 8-K jnj-20241015 0000200406 false 0000200406 2024-10-15 2024-10-15 0000200406 us-gaap:CommonStockMember 2024-10-15 2024-10-15 0000200406 jnj:A5.50NotesDue2024Member 2024-10-15 2024-10-15 0000200406 jnj:A1.150NotesDueNovember2028Member 2024-10-15 2024-10-15 0000200406 jnj:A3.20NotesDueNovember2032Member 2024-10-15 2024-10-15 0000200406 jnj:A1.650NotesDue2035Member 2024-10-15 2024-10-15 0000200406 jnj:A3.350NotesDueNovember2036Member 2024-10-15 2024-10-15 0000200406 jnj:A3.550NotesDueNovember2044Member 2024-10-15 2024-10-15 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  October 15, 2024 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 5.50% Notes Due November 2024 JNJ24BP New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 3.20% Notes Due November 2032 JNJ32 New York Stock Exchange 1.650% Notes Due May 2035 JNJ35 New York Stock Exchange 3.350% Notes Due November 2036 JNJ36A New York Stock Exchange 3.550% Notes Due November 2044 JNJ44 New York Stock Exchange Item 2.02 Results of operations and financial condition On October 15, 2024, Joh

View on Read The Filing